Combes E, Andrade A, Tosi D, Michaud H-A, Coquel F, Desigaud D, Jarlier M, Coquelle A, Pasero P, Bonnefoy N, Martineau P, Del Rio M, Beijersbergen R, Vezzio-Vie N Inhibition of Ataxia-Telangiectasia Mutated and RAD3-related (ATR) overcomes oxaliplatin resistance and promotes anti-tumor immunity in colorectal cancer. Cancer Res.. Apr 15, 2019. doi:10.1158/0008-5472.CAN-18-2807
Cherradi S, Martineau P, Gongora C, Del Rio M Claudin gene expression profiles and clinical value in colorectal tumors classified according to their molecular subtype. Cancer Manag Res. 2019;11. doi:10.2147/CMAR.S188192
Corvaglia V, Carbajo D, Prabhakaran P, Ziach K, Mandal P, Santos V, Legeay C, Vogel R, Parissi V, Pourquier P, Huc I Carboxylate-functionalized foldamer inhibitors of HIV-1 integrase and Topoisomerase 1: artificial analogues of DNA mimic proteins. Nucleic Acids Res.. May 10, 2019. doi:10.1093/nar/gkz352
Ziach K, Chollet C, Parissi V, Prabhakaran P, Marchivie M, Corvaglia V, Bose P, Laxmi-Reddy K, Godde F, Schmitter J-M, Chaignepain S, Pourquier P, Huc I Single helically folded aromatic oligoamides that mimic the charge surface of double-stranded B-DNA. Nat Chem. 2018;10(5):511-518. doi:10.1038/s41557-018-0018-7
Cherradi S, Ayrolles-Torro A, Vezzo-Vié N, Gueguinou N, Denis V, Combes E, Busson M, Canterel-Thouennon L, Mollevi C, Pugnière M, Bibeau F, Ychou M, Martineau P, Gongora C, Del Rio M Antibody targeting of claudin-1 as a potential colorectal cancer therapy. J. Exp. Clin. Cancer Res.. 2017;36(1):89. doi:10.1186/s13046-017-0558-5
Institut de Recherche en Cancérologie de
